SPECIAL SECTION—HOUSTON LUNG SYMPOSIUM
Advancing Personalized Cancer Medicine in Lung Cancer
Laura E. MacConaill, PhDArchives of Pathology & Laboratory Medicine: October 2012, Vol. 136, No. 10, pp. 1210-1216.
Although improvements in genomic technologies during the past decade have greatly advanced our understanding of the genomic alterations that contribute to lung cancer, and the disease has (to a degree) become a paradigm for individualized cancer treatment in solid tumors, additional challenges must be addressed before the goal of personalized cancer therapy can become a reality for lung cancer patients.
No comments:
Post a Comment